Relative to MassHealth managed care pharmacy benefit reimbursement rates
Summary
H1390 would amend Section 9C of Chapter 118E of the General Laws to require all MassHealth Managed Care Organizations and Accountable Care Organizations to reimburse pharmacies at the same rate described in the MassHealth Pharmacy Provider Manual. In practical terms, the bill seeks to standardize pharmacy reimbursement under MassHealth managed care arrangements so that pharmacies are paid according to the state’s pharmacy provider rules rather than potentially different rates negotiated or applied by managed care entities.
The bill also directs the Commissioner of the Division of Insurance and the Secretary of Health and Human Services to promulgate regulations to enforce the new requirement. That means the measure would not only set a reimbursement rule, but also create an administrative enforcement framework to ensure compliance across MassHealth managed care plans and accountable care organizations.
Impact
The bill would directly affect MassHealth managed care pharmacy payment practices by tying reimbursement rates to the MassHealth Pharmacy Provider Manual and limiting variation among managed care organizations and accountable care organizations. It would amend state law in Chapter 118E, which governs health care financing, and would likely influence how pharmacies are paid for prescription drug services provided to MassHealth members. The bill also expands regulatory responsibilities for the Division of Insurance and the Executive Office of Health and Human Services, which would need to issue regulations and oversee enforcement.
Sentiment
No committee transcripts or recorded votes were provided, so there is no documented legislative debate or vote history to gauge formal support or opposition. Based on the bill text alone, the measure appears aimed at protecting pharmacy reimbursement consistency within MassHealth, which suggests a policy focus on payment fairness and administrative clarity rather than a controversial restructuring of benefits. The available record does not show any expressed sentiment from legislators, agencies, pharmacies, or managed care organizations.
Contention
The likely point of contention is whether mandating uniform reimbursement rates would constrain the flexibility of MassHealth managed care organizations and accountable care organizations in designing pharmacy payment arrangements. Pharmacies may support the bill if they believe it prevents underpayment or inconsistent rates, while managed care entities may object if they view the requirement as limiting cost control or contract negotiation. Another possible issue is the need for regulations to define enforcement details, since the bill leaves implementation to the Division of Insurance and the Secretary of Health and Human Services.